Stemina Biomarker Discovery, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Stemina Biomarker Discovery, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Stemina Biomarker Discovery, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Stemina Biomarker Discovery, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
20 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Stemina Biomarker Discovery, Inc. (SBDI) is a biotechnology company that develops and commercializes molecular biomarkers for the improvement of human health and drug safety. The company provides a range of pre-clinical and specialty safety evaluation services. It develops diagnostic biomarkers of autism, cardiomyopathies, and cancer stem cells using targeted metabolomics approach. SBDI offers assays for prediction of compound and drug candidate toxicit on the developing human embryo. The companys technologies include biomarker discovery, validation, predictive toxicology and biological pathway analysis.

Stemina Biomarker Discovery, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals

  
Source:
Document ID
GDPH80709D
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Stemina Biomarker Discovery, Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Stemina Biomarker Discovery, Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Stemina Biomarker Discovery, Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Stemina Biomarker Discovery, Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Stemina Biomarker Discovery, Inc., Medical Devices Deals, 2010 to YTD 201691
Stemina Biomarker Discovery, Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016101
Stemina Biomarker Discovery, Inc., Pharmaceuticals &Healthcare, Deal Details116
  Venture Financing111
    Stemina Biomarker Discovery Raises Additional USD1.7 Million in Venture Financing111
    Stemina Biomarker Discovery Raises USD1 Million in Venture Financing121
    Stemina Biomarker Discovery Raises USD2.6 Million in Venture Financing131
  Partnerships141
    Stemina Biomarker Discovery Enters Into Co-Development Agreement With ILS141
    CIT Safety And Health Research Enters Into Agreement With Stemina Biomarker Discovery151
    Agilent Technologies Enters Into Co-Development Agreement With Stemina Biomarker161
Stemina Biomarker Discovery, Inc. - Key Competitors171
Key Employees181
Locations And Subsidiaries191
  Head Office191
  Other Locations &Subsidiaries191
Appendix201
  Methodology201
  About GlobalData201
  Contact Us201
  Disclaimer201

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Stemina Biomarker Discovery, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Stemina-Biomarker-Discovery-Inc-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-13620>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Stemina Biomarker Discovery, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Stemina-Biomarker-Discovery-Inc-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-13620>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research